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Aboriginal patients on the road 
to kidney transplantation: Is 
residence location a barrier?
KE Yeates1
Aboriginal dialysis patients have reduced access to kidney 
transplantation. The reasons for this disparity are unknown. Tonelli 
et al. show that in Canada, residence location does not significantly 
impact on an Aboriginal dialysis patient’s likelihood of receiving kidney 
transplantation. This Commentary explores the issue of decreased 
access and examines issues surrounding the findings of Tonelli et al.
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Th e burden of end-stage kidney disease is 
increasing worldwide, especially among 
Aboriginal populations. In Canada and 
elsewhere, the incidence of Aboriginal peo-
ple requiring dialysis therapy has increased 
steadily since 1980, with the rise in type 2 
diabetes mellitus in this population play-
ing an important role.1,2 Aboriginal peo-
ple have experienced a disproportionately 
high rise in the rate of end-stage kidney 
disease, with an eightfold growth in the 
number of prevalent Aboriginal patients 
on dialysis therapy in Canada.3,4 In addi-
tion, two recent Canadian analyses indicate 
that Aboriginal patients on dialysis have 
significantly lower kidney transplanta-
tion rates than non-Aboriginal patients. 
In these studies, Aboriginal patients 
received kidney transplants at 46% the 
rate of non-Aboriginal patients, and this 
disparity has continued to worsen over 
the past decade.5,6 Similar disparities exist 
for Aboriginal people in other parts of the 
developed world. A 1996 study showed 
that Native Americans in the southwestern 
United States took signifi cantly longer than 
whites to proceed to a completed trans-
plantation.7 Australian data also show that 
for the period 1993–1998, Aboriginal and 
Torres Strait Islander Australians received 
transplants at a rate 68% lower than that of 
non-indigenous Australians.8
Why does such a striking disparity exist 
for Aboriginal dialysis patients receiving 
kidney transplantation? In Canada, it is 
known that Aboriginal patients are less 
likely than non-Aboriginal Canadians to 
receive a kidney transplant from a living 
donor.6 The low rate of living donation 
(which may be due to medical unsuitabil-
ity among potential family donors) leaves 
Aboriginal patients reliant on access to 
transplant kidneys through the deceased-
donor pathway. Patients awaiting deceased-
donor kidneys wait significantly longer 
than those who receive kidney transplants 
from living donors. In addition, little 
is known about whether differences in 
blood group or human leukocyte antigen 
haplotype might aff ect organ allocation of 
deceased donor kidneys to Aboriginal ver-
sus non-Aboriginal patients.
Further evidence suggests that delays 
exist at each of the stages of the transplan-
tation process, from the commencement 
of dialysis and wait-listing to the success-
ful completion of a renal transplantation. 
A recent Canadian study has determined 
that Aboriginal dialysis patients in the 
province of Alberta get referred for kidney 
transplantation assessment at the same 
rate as non-Aboriginal patients. However, 
once they get referred, there is a signifi cant 
delay to completion of the transplantation 
work-up and wait-listing for transplanta-
tion in comparison with non-Aboriginal 
dialysis patients.9
Exploration of potential barriers to 
transplantation access should be informed 
by the knowledge that kidney transplan-
tation takes place aft er completion of a 
number of essential steps, each of which 
may represent a barrier to transplanta-
tion.10 In order to receive a transplant, a 
new dialysis patient must, in principle, be 
referred for transplantation assessment, 
receive patient education, and provide 
informed consent to proceed through the 
transplantation work-up process. Only 
once the transplantation work-up is suc-
cessfully completed, and if he or she is 
deemed medically suitable, can a patient 
be wait-listed. Once on the waiting list, 
the patient must remain ‘active’ and be 
deemed healthy enough (and be avail-
able) to undergo transplantation when 
a deceased-donor kidney is off ered. It is 
conceivable that any of these steps may act 
as a barrier to any patient who is proceed-
ing to kidney transplantation. However, 
for Aboriginal dialysis patients, additional 
delays may occur at diff erent points of the 
process because of diff erences in language, 
transplant preferences, fear, cultural and 
spiritual beliefs, and, potentially, their 
residence location. It would seem reason-
able to suggest that this delay in work-up 
might be aff ected by a geographic barrier 
such as remote residence location.
Tonelli and colleagues11 (this issue) 
have attempted to clarify whether resi-
dence location is a barrier that may delay 
or halt Aboriginal patients from receiv-
ing a completed kidney transplantation. 
Research in the area of barriers to kidney 
transplantation is limited, and studies 
such as that of Tonelli and colleagues11 
will help to shed light on the problem and 
provide answers to specific questions. 
Th e hypothesis that the distance traveled 
by a dialysis patient to the nearest renal 
transplantation center might impact on 
the likelihood of his or her receiving a 
kidney transplant is a reasonable one, 
especially given the vast geographic areas 
in which Aboriginal patients may reside 
in Canada. Many Aboriginal reserves are 
located in geographically remote areas, 
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some of which are accessible only by air 
or ice road in the winter months. Figure 
1 describes the population density of 
Canada’s Aboriginal people. Rural and 
remote residence location is also an issue 
in Australia, where Aboriginal people and 
Torres Strait Islanders are more likely to 
live in remote areas of the outback or in 
isolated areas of the Northern Territory. In 
the United States, Native Americans may 
also live in locations geographically iso-
lated from their regional transplantation 
centers, especially in states with large rural 
health regions. Although it has been previ-
ously hypothesized, there are no previous 
reports to suggest that residence loca-
tion is associated with decreased access 
to kidney transplantation. Tonelli et al.11 
fi nd that distance from the transplanting 
center does not contribute signifi cantly to 
this delay.
Given Canada’s vast size and hetero-
geneous geographic environment, it is 
surprising that residence location had no 
impact on the likelihood of Aboriginal 
patients’ receiving a kidney transplant in 
Canada. Given the disparity that exists 
in access to kidney transplantation for 
Aboriginal people, this fi nding deserves 
thoughtful consideration. One way to 
interpret this result is that it is valid and 
that in Canada, despite our large geo-
graphic size, there is no identifi able link 
between residence location and the dispar-
ity in Aboriginal access to transplantation. 
Readers of the study results may come 
away with the impression that the Cana-
dian health-care system (which is based on 
universality) might have somehow found a 
way to provide special access to health-care 
services for those who might be disadvan-
taged by living in the most geographically 
remote residence locations. As the authors 
carefully point out, the study results per-
tain only to Canada and would need to be 
validated in other locations where Abo-
riginal people also have decreased access 
to transplantation.
But this interpretation seems counter-
intuitive to what I have experienced in the 
challenges of providing timely and eff ec-
tive health care to remote-living Abo-
riginal patients who are cared for in our 
center’s own remote dialysis program.
Alternatively, we can guess that the 
study methodology has failed to capture 
residence location as a true transplanta-
tion barrier. Perhaps the use of registry 
data and patient postal codes to calculate 
distances traveled to the nearest trans-
plantation center does not accurately 
refl ect a patient’s true residence. Perhaps 
the travel times that were so carefully 
estimated do not refl ect other issues such 
as time required to arrange and take a 
fl ight (where necessary) in order to reach 
a tertiary-care center. Perhaps the small 
number of the ‘remotest’ patients failed 
to reach signifi cance. What about Abo-
riginal patients who have relocated for 
dialysis therapy? Th ey may have moved 
to a residence location that is geographi-
cally closer to the transplantation center, 
but perhaps this move away from their 
community and cultural center has cre-
ated personal isolation that renders them 
unable to appropriately complete a trans-
plantation work-up. Would this be cap-
tured by a mathematical calculation of 
distances traveled? Furthermore, does a 
distance of 10 km diff er from 100 km if 
you do not have the fi nancial resources to 
get from point A to point B?
Nevertheless, the lack of association 
between residence location and likelihood 
of receiving a kidney transplant should 
emphasize to researchers and policy makers 
that the problem is more complex than just 
geography. It does not ‘let us off  the hook’ 
but instead should highlight the need for 
focused and thoughtful investigation into 
the broader issue of inequality in access to 
many levels of the health-care system. In 
many ways, Aboriginal access to kidney 
transplantation is a powerful metaphor 
for the overwhelming issue of health-care 
disparities that exist for many Aboriginal 
populations in the developed world.
It is therefore instructive to examine 
and question Aboriginal peoples’ access 
to kidney transplantation in the context 
of broader institutionalized inequalities 
within health-care systems. By examin-
ing the Aboriginal patient’s experience 
of the kidney transplantation process, 
we may be better able to understand 
where these barriers may exist both for 
the individual patient and in the broader 
context of the health-care system. Fur-
thermore, it may be possible to diminish, 
eliminate, or modify specifi c barriers. 
In this way, over time, access to kidney 
transplantation for Aboriginal people 
might signifi cantly improve.
REFERENCES
1. McDonald SP, Russ GR. Burden of end-stage renal 
disease among indigenous peoples in Australia and 
New Zealand. Kidney Int Suppl 2003; S123–S127.
1,000 km
Aboriginal population (%)
 0 – 2
 2 – 4
 4 – 6
 6 – 8
 8 – 10
10 – 15
15 – 20
 20 – 25
 25 – 50
 50 – 100
Figure 1 | Population density of Aboriginal people: Canada.11
A
nn
 T
ho
m
ps
on
828   Kidney International (2006) 70
commentar y
2. Narva AS. The spectrum of kidney disease in 
American Indians. Kidney Int Suppl 2003; S3–S7.
3. Dyck RF. Mechanisms of renal disease in 
indigenous populations: influences at work in 
Canadian indigenous peoples. Nephrology 2001; 
6: 3–7.
4. Canadian Organ Replacement Register. 2001 
Annual Report. Volume 1: Dialysis and Renal 
Transplantation. Canadian Institute for Health 
Information, Ottawa, Canada, 2001.
5. Tonelli M, Hemmelgarn B, Manns B et al. Death and 
renal transplantation among Aboriginal people 
undergoing dialysis. CMAJ 2004; 171: 577–582.
6. Yeates K, Schuabel D, Cass A et al. Access to renal 
transplantation for minority patients with end-
stage renal disease in Canada. Am J Kidney Dis 
2004; 44: 1083–1089.
7. Narva A, Stiles S, Karp S, Turak A. Access of native 
Americans to renal transplantation in Arizona and 
new Mexico. Blood Purif 1996; 14: 243–204.
8. Cass A, Cunningham J, Snelling P et al. Renal 
transplantation for indigenous Australians: 
identifying barriers to equitable access. Ethn 
Health 2003; 8: 111–119.
9. Tonelli M, Chou S, Gourishankar S et al. Wait-listing 
for kidney transplantation among Aboriginal 
hemodialysis patients. Am J Kidney Dis 2005; 46: 
1117–1123.
10. Alexander GC, Sehgal AR. Barriers to cadaveric 
renal transplantation among blacks, women, and 
the poor. JAMA 1998; 280: 1148–1152.
11. Tonelli M, Hemmelgarn B, Kim AKJ et al. 
Association between residence location and 
likelihood of kidney transplantation in Aboriginal 
patients treated with dialysis in Canada. Kidney Int 
2006; 70: 924–930. 
see original article on page 865
Making sense of the sensor: 
Mysteries of the macula densa
RC Blantz1
Increases in luminal NaCl concentration at the macula densa (MD), 
the sensing element, activate tubuloglomerular feedback (TGF). MD 
cell volume increases when increments are isosmotic and shrinks if 
osmolality increases. This interesting finding introduces additional 
complexity to the role of the MD in TGF.
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At first glance the article by Komlosi 
and colleagues1 (this issue) may appear 
a study in parochial basic science focus-
ing on tubular luminal factors that reg-
ulate the cell volume of a peculiar cell, 
the macula densa (MD), located in the 
distal nephron. Th is would be wrong. 
For several historical, physiologic, and 
clinically relevant reasons, the infor-
mation is important and a necessary 
step in progress to our understanding 
of the role of the kidney in maintain-
ing NaCl and volume homeostasis. It is 
now accepted that the tubuloglomerular 
feedback (TGF) system plays a legitimate 
physiologic role in maintaining stability 
of kidney function by (1) sustaining a 
relationship between tubular reabsorp-
tion and the fi ltered load or glomerular 
fi ltration rate (GFR), (2) contributing 
signifi cantly to the effi  ciency of autoreg-
ulation of kidney blood fl ow and GFR, 
and (3) providing a system that can tem-
porally adapt or reset to newly imposed 
physiologic circumstance.2 Th e sensing 
limb of this cybernetic system is housed 
within MD cells that are connected via 
extraglomerular mesangial cells to the 
glomerular aff erent arteriole and glomer-
ulus to constitute the juxtaglomerular 
apparatus.3 It is therefore important to 
defi ne the boundary conditions of how 
changes in solute and NaCl delivery 
aff ect the transport and sensing func-
tions of the MD. Komlosi et al.1 defi ne 
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important aspects of how luminal NaCl 
concentration and osmotic pressure sep-
arately infl uence the sensor (Figure 1), a 
cell with attributes diff erent from those 
of adjacent thick ascending limb cells. 
Debates on the nature of the aff erent 
signaling mechanisms of TGF date back 
several decades and represent interesting 
history in scientifi c investigation. Major 
physiologists in the mid-1960s, includ-
ing Arthur Guyton and Klaus Th urau, 
espoused hypotheses regarding a TGF 
system.4,5 Guyton and colleagues pro-
posed that changes in flow to the MD 
would produce changes in renal blood 
flow by sensing osmolality and solute 
delivery, not just NaCl.4 Thurau and 
Schnermann argued that luminal NaCl 
concentration and NaCl reabsorption 
constituted the signal at the MD.5 Schner-
mann, Wright, and co-workers soon 
thereaft er supplied the fi rst objective data 
on which to base conclusions on the role 
of osmolality versus NaCl as the MD sig-
nal of TGF.6,7 In nephron microperfusion 
studies, increasing late proximal flow 
with NaCl/HCO3 solutions from normal 
to elevated values reduced nephron GFR 
by approximately 10 nl/min. However, 
solutions containing isotonic mannitol 
or mannitol and Na2SO4 produced no 
TGF response. Blantz and Konnen soon 
thereafter demonstrated that isotonic 
addition of solutes such as glucose and 
amino acids to perfusion fl uids (5 mM, 
respectively) produced approximately 
60% reductions in the magnitude of TGF 
responses.8 Addition of non-electrolyte 
solutes did not alter the rise in chloride 
concentration in distal tubular fl uid nor 
the osmolality but was associated with 
an approximately 20% reduction in chlo-
ride reabsorption between late proximal 
and early distal tubules, suggesting a 
reduction in chloride transport, possibly 
including the MD. 
Th e study by Komlosi et al.1 deline-
ates the separate eff ects of luminal NaCl 
concentration and luminal osmolality 
by examining parallel changes in MD 
cell volume. An increase in MD lumi-
nal NaCl at constant luminal osmolality 
caused a reversible signifi cant increase in 
MD cell volume (Figure 1). Concurrent 
application of furosemide eliminated 
83% of this cell swelling, suggesting that 
